A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)
| Autor: | Shah, Ruchitbhai, Botteman, Marc, Solem, Caitlyn T., Luo, Linlin, Doan, Justin, Cella, David, Motzer, Robert J. |
|---|---|
| Zdroj: | In Clinical Genitourinary Cancer October 2019 17(5):356-365 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect